Application of the PET ligand [C-11]ORM-13070 to examine receptor occupancy by the alpha(2C)-adrenoceptor antagonist ORM-12741: translational validation of target engagement in rat and human brain

dc.contributor.authorShahid Mohammed
dc.contributor.authorRinne Juha O
dc.contributor.authorScheinin Mika
dc.contributor.authorVirta Jere
dc.contributor.authorMarjamäki Päivi
dc.contributor.authorSolin Olof
dc.contributor.authorArponen Eveliina
dc.contributor.authorSallinen Jukka
dc.contributor.authorKuokkanen Katja
dc.contributor.authorRouru Juha
dc.contributor.organizationfi=MediCity|en=MediCity|
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=kemian laitos|en=Department of Chemistry|
dc.contributor.organizationfi=kliininen fysiologia ja isotooppilääketiede|en=Clinical Physiology and Isotope Medicine|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.contributor.organization-code1.2.246.10.2458963.20.27622076134
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.contributor.organization-code2607322
dc.contributor.organization-code2609810
dc.converis.publication-id51368765
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/51368765
dc.date.accessioned2022-10-28T13:41:15Z
dc.date.available2022-10-28T13:41:15Z
dc.description.abstract<b>Background</b><div>Availability of the α<sub>2C</sub>-adrenoceptor (α2C-AR) positron emission tomography (PET) tracer, [<sup>11</sup>C]ORM-13070, and the α2C-AR antagonist ORM-12741 allows probing of the roles of this G-protein coupled receptor subtype in brain function, both in healthy humans and in patients with various brain disorders. This translational study employed [11C]ORM-13070 autoradiography and PET to determine α2C-AR occupancy by ORM-12741 in rat and human brain, respectively.</div><div><br /></div><div><b>Results</b></div><div>ORM-12741 has high affinity (K<sub>i</sub>: 0.08 nM) and potent antagonist activity (K<sub>b</sub>: 0.04 nM) as well as selectivity (K<sub>i</sub> estimates for the humanα2A-AR and α2B-AR were 8.3 nM and 0.8 nM, respectively) for the human α2C-AR subtype. [11C]ORM-13070 had highest uptake in the basal ganglia of rat and human brain. Pretreatment with ORM-12741 inhibited [11C]ORM-13070 binding in rat striatum in a time- and dose-dependent manner at 10 and 50 µg/kg (s.c.) with an EC<sub>50</sub> estimate of 1.42 ng/mL in rat plasma, corresponding to protein-free drug concentration of 0.23 nM. In the living human brain, time- and dose-related α2C-AR occupancy was detected with EC50 estimates of 24 ng/mL and 31 ng/mL for the caudate nucleus and putamen, respectively, corresponding to protein-free concentrations in plasma of 0.07 nM and 0.1 nM. Modelling-based maximum α2C-AR occupancy estimates were 63% and 52% in the caudate nucleus and the putamen, respectively.</div><div><br /></div><div><b>Conclusions</b></div><div>ORM-12741 is a selective α2C-AR antagonist which penetrates the rat and human brain to occupy α2C-ARs in a manner consistent with its receptor pharmacology.</div><div><br /></div><div>Trial registration number and date of registration: ClinicalTrial.cov NCT00829907. Registered 11 December 2008. https://clinicaltrials.gov/.</div>
dc.identifier.eissn2191-219X
dc.identifier.jour-issn2191-219X
dc.identifier.olddbid183624
dc.identifier.oldhandle10024/166718
dc.identifier.urihttps://www.utupub.fi/handle/11111/34204
dc.identifier.urnURN:NBN:fi-fe2021042822930
dc.language.isoen
dc.okm.affiliatedauthorRinne, Juha
dc.okm.affiliatedauthorScheinin, Mika
dc.okm.affiliatedauthorVirta, Jere
dc.okm.affiliatedauthorMarjamäki, Päivi
dc.okm.affiliatedauthorSolin, Olof
dc.okm.affiliatedauthorArponen, Eveliina
dc.okm.affiliatedauthorDataimport, MediCity
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3126 Surgery, anesthesiology, intensive care, radiologyen_GB
dc.okm.discipline3126 Kirurgia, anestesiologia, tehohoito, radiologiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherSPRINGER
dc.publisher.countryGermanyen_GB
dc.publisher.countrySaksafi_FI
dc.publisher.country-codeDE
dc.relation.articlenumberARTN 152
dc.relation.doi10.1186/s13550-020-00741-y
dc.relation.ispartofjournalEJNMMI Research
dc.relation.issue1
dc.relation.volume10
dc.source.identifierhttps://www.utupub.fi/handle/10024/166718
dc.titleApplication of the PET ligand [C-11]ORM-13070 to examine receptor occupancy by the alpha(2C)-adrenoceptor antagonist ORM-12741: translational validation of target engagement in rat and human brain
dc.year.issued2020

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
ShahidEtAl2020ApplicationOfThePETLigand.pdf
Size:
1.29 MB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF